Intrabody construction and expression. I. The critical role of V(L) domain stability

Journal of Molecular Biology

Volumn 291, Issue 5, 1999, Pages 1119-1128

  Ohage, Ettore ^a   Steipe, Boris ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Intrabodies; Protein engineering; Protein stability; Recombinant expression; V(L) domain

Indexed keywords

CYSTEINE; IMMUNOGLOBULIN; METHIONINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIOPHAGE T7; CELL INCLUSION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOPLASM; GENETIC ENGINEERING; IMMUNOGLOBULIN VARIABLE REGION; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; THERMOSTABILITY;

EID: 0033520343     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3019     Document Type: Article

References (29)

1. Better M., Horwitz A. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041-1043.
2. Chan W., Helms L. R., Brooks I., Lee G., Ngola S., McNulty D., Maleeff B., Hensley P., Wetzel R. Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin VL domain REI. Fold. Design. 1:1996;77-89.
3. Frisch C., Kolmar H., Fritz H. A soluble immunoglobulin variable domain without a disulfide bridge: construction, accumulation in the cytoplasm ofE. coli , purification and physicochemical characterization. Biol. Chem. Hoppe-Seyler. 375:1994;353-356.
4. V, the variable domain of a human immunoglobulin κ light chain. Fold. Design. 1:1996;431-440.
5. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
6. Glockshuber R., Schmidt T., Plückthun A. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. Biochemistry. 31:1992;1270-1279.
7. Goto Y., Hamaguchi K. Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. kinetic role of the intrachain disulfide bond. J. Mol. Biol. 156:1982;911-926.
8. Guo J., Huang W., Scanlan T. S. Kinetic and mechanistic characterization of an efficient hydrolytic antibody: Evidence for the formation of an acyl intermediate. J. Am. Chem. Soc. 116:1994;6062-6069.
9. Hirel P. H., Schmitter M. J., Dessen P., Fayat G., Blanquet S. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc. Natl Acad. Sci. USA. 86:1989;8247-8251.
10. Hoogenboom H. R., de B. A., Hufton S. E., Hoet R. M., Arends J. W., Roovers R. C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1-20.
11. Hudson P. J. Recombinant antibody fragments. Curr. Opin. Biotechnol. 9:1998;395-402.
12. Ishikawa N., Chiba T., Chen L. T., Shimizu A., Ikeguchi M., Sugai S. Remarkable destabilization of recombinant alpha-lactalbumin by an extraneous N-terminal methionyl residue. Protein Eng. 11:1998;333-335.
13. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Distribution Files of the Fifth Edition of Sequences of Proteins of Immunological Interest, http://immuno.bme.nwu.edu/. 1992.
14. Knappik A., Plückthun A. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng. 8:1995;81-89.
15. Lindner P., Bauer K., Krebber A., Nieba L., Kremmer E., Krebber C., Honegger A., Klinger B., Mocikat R., Plückthun A. Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. Biotechniques. 22:1997;140-149.
16. Martineau P., Jones P., Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J. Mol. Biol. 280:1998;117-127.
17. Ohage E. C., Graml W., Walter M. M., Steinbacher S., Steipe B. Beta-turn propensities as paradigms for the analysis of structural motifs to engineer protein stability. Protein Sci. 6:1997;233-241.
18. Ohage E. C., Wirtz P., Barnikow J., Steipe B. Intrabody construction and expression II: A synthetic catalytic Fv. J. Mol. Biol. 291:1999;1129-1134.
19. 1with zero, one, and two intact disulfide bonds. J. Biol. Chem. 263:1988;11820-11825.
20. Padlan E. A. X-Ray chrystallography of antibodies. Advan. Protein Chem. 49:1996;57-133.
21. Pai L. H., Wittes R., Setser A., Willingham M. C., Pastan I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nature Med. 2:1996;350-353.
22. Proba K., Worn A., Honegger A., Plückthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275:1998;245-253.
23. Schellman J. A. Solvent denaturation. Biopolymers. 17:1978;1305-1322.
24. Schoepfer R. The pRSET family of T7 promoter expression vectors for Escherichia coli. Gene. 124:1993;83-85.
25. Skerra A. Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli. Gene. 151:1994;131-135.
26. vfragment in Escherichia coli. Science. 240:1988;1038-1041.
27. Steipe B., Schiller B., Plückthun A., Steinbacher S. Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240:1994;188-192.
28. Uson I., Bes M., Sheldrick G., Schneider T., Hartsch T., Fritz H. X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain. Fold. Design. 2:1997;357-361.
29. Wirtz P., Steipe B. Intrabody construction and expression III: Engineering hyperstable VH domains. Protein Sci. 1999.